Report cover image

Menstrual Cups Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032

Publisher Fortune Business Insights Pvt. Ltd.
Published May 01, 2024
Length 149 Pages
SKU # FOB18820081

Description

Menstrual Cups Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032



Growth Factors of Menstrual Cups Market

The menstrual cups size was valued at USD 1.43 billion in 2023, and the market is now projected to grow from USD 1.50 billion in 2024 to USD 2.48 billion by 2032, exhibiting a CAGR of 6.5% during the forecast period of 2024-2032.

The COVID-19 pandemic initially disrupted the menstrual cup marketplace due to deliver chain disruptions and shortages. However, as regulations eased in past due 2021, reputation for natural and reusable menstrual products grew, leading to a resurgence in market increase in 2021 and 2022.

The worldwide adoption of menstrual cups has been step by step developing, pushed through way of developing cognizance amongst girls of their benefits. Manufacturers are innovating to decorate comfort and offer customized alternatives with various styles and sizes. Factors like cost-effectiveness, sustainability, and luxury similarly raise name for, contributing to marketplace boom.

Menstrual cups provide a sustainable technique to menstrual hygiene, notably decreasing waste as compared to disposable pads and tampons. With their reusable nature lasting as lots as 12 months. They reduce environmental effect and make contributions to green menstrual practices.

Comprehensive Analysis Menstrual Cups Market

The menstrual cups growth is rising at an exponential rate due to its market segmentation. This market expansion effectively provides a detailed regional assessment considering the dominant supply and demand forces that impact the industry. These segmentations are methodically segregated By Type Analysis, By Material Type Analysis, By Distribution Channel Analysis. By Type Analysis include, with reusable and disposable product. By Material Type Analysis include, silicone, latex, and thermoplastic elastomer, By Distribution Channel Analysis include, hospital pharmacies, retail pharmacies & drug stores, and online pharmacies.

North America region lead the menstrual cups market share by benefitting a market size of USD 0.70 billion in 2023 due to the increasing adoption rate of menstrual hygiene products in North America is fueled by both the availability of a wide range of products and high awareness among women in the region.

The top gamers inside the market play a critical role in the industry assuring market boom and placing marketplace standards. These players include Sirona Hygiene, Procter & Gamble, Mooncup Ltd, Redcliffe Hygiene, Diva International, CS Technologies, Anigan, Me Luna, The Flex Company, Ruby Cup, Fleurcup, INTIMINA, Saalt. These market players provide a level playing competitive landscape.

In December 2023, The Flex Company's acquisition of All bodies Inc. and their sales of over 130.0 million units since 2016 have propelled them to surpass menstrual cups in U.S. sales, marking a significant milestone in women's health.

Segmentation Table

REPORT SCOPE & SEGMENTATION

ATTRIBUTE DETAILS

Study Period 2019-2032

Base Year 2023

Estimated Year 2024

Forecast Period 2024-2032

Historical Period 2019-2022

Unit Value (USD Billion)

Growth Rate CAGR of 6.5% from 2024-2032

Segmentation By Type

Disposable

Reusable

By Material Type

Silicone

Latex

Thermoplastic Elastomer

By Distribution Channel

Hospital Pharmacies

Retail Pharmacies & Drug Stores

Online Pharmacies

By Region

North America

- U.S. (By Type)

- Canada (By Type)

Europe

- Germany (By Type)

- U.K. (By Type)

- France (By Type)

- Italy (By Type)

- Spain (By Type)

- Scandinavia (By Type)

- Rest of Europe (By Type)

Asia Pacific

- China (By Type)

- Japan (By Type)

- India (By Type)

- Australia (By Type)

- Southeast Asia (By Type)

- Rest of Asia Pacific (By Type)

Rest of the World


Please Note: It will take 5-6 business days to complete the report upon order confirmation.

Table of Contents

149 Pages
1. Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Market Trends
4. Key Insights
4.1. Prevalence of Chronic Diseases, by Key Countries/Regions, 2022/2023
4.2. Pipeline Analysis, By Key Players
4.3. Technological Advancements
4.4. New Product Launches, By Key Players
4.5. Key Industry Developments: Mergers, Acquisitions & Partnerships
4.6. Impact of COVID-19 on the Market
5. Global CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
5.1. Market Analysis, Insights and Forecast – By Drug Type
5.1.1. Axicabtagene Ciloleucel (Yescarta)
5.1.2. Brexucabtagene Autoleucel (Tecartus)
5.1.3. Ciltacabtagene Autoleucel (Carvykti)
5.1.4. Idecabtagene Vicleucel (Abecma)
5.1.5. Lisocabtagene Maraleucel (Breyanzi)
5.1.6. Tisagenlecleucel (Kymriah)
5.1.7. Others
5.2. Market Analysis, Insights and Forecast – By Indication
5.2.1. Acute lymphoblastic leukemia
5.2.2. Non-Hodgkin lymphoma
5.2.3. Multiple Myeloma
5.3. Market Analysis, Insights and Forecast – By End User
5.3.1. Hospitals
5.3.2. Oncology Treatment Centers
5.4. Market Analysis, Insights and Forecast – By Region
5.4.1. North America
5.4.2. Europe
5.4.3. Asia Pacific
5.4.4. Rest of the World
6. North America CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
6.1. Market Analysis, Insights and Forecast – By Drug Type
6.1.1. Axicabtagene Ciloleucel (Yescarta)
6.1.2. Brexucabtagene Autoleucel (Tecartus)
6.1.3. Ciltacabtagene Autoleucel (Carvykti)
6.1.4. Idecabtagene Vicleucel (Abecma)
6.1.5. Lisocabtagene Maraleucel (Breyanzi)
6.1.6. Tisagenlecleucel (Kymriah)
6.1.7. Others
6.2. Market Analysis, Insights and Forecast – By Indication
6.2.1. Acute lymphoblastic leukemia
6.2.2. Non-Hodgkin lymphoma
6.2.3. Multiple Myeloma
6.3. Market Analysis, Insights and Forecast – By End User
6.3.1. Hospitals
6.3.2. Oncology Treatment Centers
6.4. Market Analysis, Insights and Forecast – By Country
6.4.1. U.S.
6.4.2. Canada
7. Europe CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
7.1. Market Analysis, Insights and Forecast – By Drug Type
7.1.1. Axicabtagene Ciloleucel (Yescarta)
7.1.2. Brexucabtagene Autoleucel (Tecartus)
7.1.3. Ciltacabtagene Autoleucel (Carvykti)
7.1.4. Idecabtagene Vicleucel (Abecma)
7.1.5. Lisocabtagene Maraleucel (Breyanzi)
7.1.6. Tisagenlecleucel (Kymriah)
7.1.7. Others
7.2. Market Analysis, Insights and Forecast – By Indication
7.2.1. Acute lymphoblastic leukemia
7.2.2. Non-Hodgkin lymphoma
7.2.3. Multiple Myeloma
7.3. Market Analysis, Insights and Forecast – By End User
7.3.1. Hospitals
7.3.2. Oncology Treatment Centers
7.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
7.4.1. U.K.
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Scandinavia
7.4.7. Rest of Europe
8. Asia Pacific CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
8.1. Market Analysis, Insights and Forecast – By Drug Type
8.1.1. Axicabtagene Ciloleucel (Yescarta)
8.1.2. Brexucabtagene Autoleucel (Tecartus)
8.1.3. Ciltacabtagene Autoleucel (Carvykti)
8.1.4. Idecabtagene Vicleucel (Abecma)
8.1.5. Lisocabtagene Maraleucel (Breyanzi)
8.1.6. Tisagenlecleucel (Kymriah)
8.1.7. Others
8.2. Market Analysis, Insights and Forecast – By Indication
8.2.1. Acute lymphoblastic leukemia
8.2.2. Non-Hodgkin lymphoma
8.2.3. Multiple Myeloma
8.3. Market Analysis, Insights and Forecast – By End User
8.3.1. Hospitals
8.3.2. Oncology Treatment Centers
8.4. Market Analysis, Insights and Forecast – By Country/ Sub-Region
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Australia
8.4.5. Southeast Asia
8.4.6. Rest of Asia Pacific
9. Rest of the World CAR-T Cell Therapy Market Analysis, Insights and Forecast, 2019-2032
9.1. Market Analysis, Insights and Forecast – By Drug Type
9.1.1. Axicabtagene Ciloleucel (Yescarta)
9.1.2. Brexucabtagene Autoleucel (Tecartus)
9.1.3. Ciltacabtagene Autoleucel (Carvykti)
9.1.4. Idecabtagene Vicleucel (Abecma)
9.1.5. Lisocabtagene Maraleucel (Breyanzi)
9.1.6. Tisagenlecleucel (Kymriah)
9.1.7. Others
9.2. Market Analysis, Insights and Forecast – By Indication
9.2.1. Acute lymphoblastic leukemia
9.2.2. Non-Hodgkin lymphoma
9.2.3. Multiple Myeloma
9.3. Market Analysis, Insights and Forecast – By End User
9.3.1. Hospitals
9.3.2. Oncology Treatment Centers
10. Competitive Analysis
10.1. Global Market Share Analysis (2023)
10.2. Company Profiles
10.2.1. Gilead Sciences, Inc.
10.2.1.1. Overview
10.2.1.2. Products & Services
10.2.1.3. SWOT Analysis
10.2.1.4. Recent Developments
10.2.1.5. Strategies
10.2.1.6. Financials (Based on Availability)
10.2.2. Novartis AG
10.2.2.1. Overview
10.2.2.2. Products & Services
10.2.2.3. SWOT Analysis
10.2.2.4. Recent Developments
10.2.2.5. Strategies
10.2.2.6. Financials (Based on Availability)
10.2.3. Bristol-Myers Squibb Company
10.2.3.1. Overview
10.2.3.2. Products & Services
10.2.3.3. SWOT Analysis
10.2.3.4. Recent Developments
10.2.3.5. Strategies
10.2.3.6. Financials (Based on Availability)
10.2.4. Johnson & Johnson Services, Inc. (Janssen Global Services, LLC)
10.2.4.1. Overview
10.2.4.2. Products & Services
10.2.4.3. SWOT Analysis
10.2.4.4. Recent Developments
10.2.4.5. Strategies
10.2.4.6. Financials (Based on Availability)
10.2.5. Caribou Biosciences, Inc.
10.2.5.1. Overview
10.2.5.2. Products & Services
10.2.5.3. SWOT Analysis
10.2.5.4. Recent Developments
10.2.5.5. Strategies
10.2.5.6. Financials (Based on Availability)
10.2.6. CARsgenTherapeutics Co., Ltd
10.2.6.1. Overview
10.2.6.2. Products & Services
10.2.6.3. SWOT Analysis
10.2.6.4. Recent Developments
10.2.6.5. Strategies
10.2.6.6. Financials (Based on Availability)
10.2.7. JW Therapeutics (Shanghai) Co., Ltd.
10.2.7.1. Overview
10.2.7.2. Products & Services
10.2.7.3. SWOT Analysis
10.2.7.4. Recent Developments
10.2.7.5. Strategies
10.2.7.6. Financials (Based on Availability)
10.2.8. Cartesian Therapeutics, Inc.
10.2.8.1. Overview
10.2.8.2. Products & Services
10.2.8.3. SWOT Analysis
10.2.8.4. Recent Developments
10.2.8.5. Strategies
10.2.8.6. Financials (Based on Availability)
10.2.9. Aurora Biopharma
10.2.9.1. Overview
10.2.9.2. Products & Services
10.2.9.3. SWOT Analysis
10.2.9.4. Recent Developments
10.2.9.5. Strategies
10.2.9.6. Financials (Based on Availability)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us